» Articles » PMID: 18190303

Strategies for Primary HIV Prevention That Target Behavioral Change

Overview
Journal Clin Infect Dis
Date 2008 Feb 8
PMID 18190303
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In the absence of a vaccine or cure, behavioral change remains the major method to prevent transmission of the human immunodeficiency virus (HIV). Public awareness campaigns that disseminate information about the risks and routes of transmission, although important, have an insufficient influence on the behavioral changes essential to reduce the risk of HIV infection. Because of the complex interplay of cultural and psychosocial influences that guides human behavior, specific programs to decrease high-risk behavior have been developed for target populations. In this report, tested initiatives for preventing HIV infection are summarized and their success evaluated for men who have sex with men, injection drug users, and women of minority racial groups. Objective evidence of reductions in high-risk behavior in these 3 groups, which account for the majority of HIV transmissions in the United States, has critical implications for reducing the overall rate of new HIV infections.

Citing Articles

Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial.

Zelenev A, Huedo-Medina T, Shrestha R, Mistler C, Altice F, Sibilio B PLoS One. 2024; 19(11):e0312165.

PMID: 39509356 PMC: 11542883. DOI: 10.1371/journal.pone.0312165.


A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Shrestha R, Krishnan A, Altice F, Copenhaver M Contemp Clin Trials. 2015; 44:95-102.

PMID: 26253181 PMC: 4744142. DOI: 10.1016/j.cct.2015.08.002.


Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions.

Springer S, Larney S, Alam-Mehrjerdi Z, Altice F, Metzger D, Shoptaw S J Acquir Immune Defic Syndr. 2015; 69 Suppl 2:S155-61.

PMID: 25978482 PMC: 4443704. DOI: 10.1097/QAI.0000000000000637.


Epidemiological knowledge on human immunodeficiency virus infection as a basic for programme of prophylactic measures.

Azovtseva O, Arkhipov G Environ Health Prev Med. 2015; 20(2):137-40.

PMID: 25712588 PMC: 4597354. DOI: 10.1007/s12199-015-0450-x.


Setting the bar high or setting up to fail? Interpretations and implications of the EXPLORE Study (HPTN 015).

Kalichman S, Zohren L, Eaton L AIDS Behav. 2013; 18(4):625-33.

PMID: 23989823 PMC: 4299583. DOI: 10.1007/s10461-013-0603-0.